Citations to this article

Sizhi Paul Gao, Kevin G. Mark, Kenneth Leslie, William Pao, Noriko Motoi, William L. Gerald, William D. Travis, William Bornmann, Darren Veach, Bayard Clarkson, Jacqueline F. Bromberg
Published in Volume 117, Issue 12
J Clin Invest. 2007; 117(12):3846–3856 doi:10.1172/JCI31871

Total citations by year in Crossref

Year: 2014 2013 2012 2011 2010 2009 2008 Total
Citations: 20 21 19 12 13 16 4 105
Citation information

Citations to this article in Crossref (105)

Title and authors Publication Year
Radioimmunoimaging with Mixed Monoclonal Antibodies of Nude Mice Bearing Human Lung Adenocarcinoma Xenografts
D Duan, SL Li, YQ Zhu, T Zhang, CM Lei, XH Cheng
Asian Pacific Journal of Cancer Prevention 2012
STAT3 as a therapeutic target for Epstein-Barr virus (EBV) – associated nasopharyngeal carcinoma
Y Ho, SW Tsao, M Zeng, VW Lui
Cancer Letters 2012
Overexpression of signal transducer and activator of transcription (STAT-3 and STAT-5) transcription factors and alteration of suppressor of cytokine signaling (SOCS-1) protein in prostate cancer
N Singh, S Hussain, M Bharadwaj, N Kakkar, SK Singh, RC Sobti
Journal of Receptors and Signal Transduction 2012
DNA damage induces the IL-6/STAT3 signaling pathway, which has anti-senescence and growth-promoting functions in human tumors
UJ Yun, SE Park, YS Jo, J Kim, DY Shin
Cancer Letters 2012
PNAS Plus: STAT3 negatively regulates thyroid tumorigenesis
JP Couto, L Daly, A Almeida, JA Knauf, JA Fagin, M Sobrinho-Simoes, J Lima, V Maximo, P Soares, D Lyden, JF Bromberg
Proceedings of the National Academy of Sciences 2012
Interleukin-6 signaling pathway in targeted therapy for cancer
Y Guo, F Xu, TJ Lu, Z Duan, Z Zhang
Cancer Treatment Reviews 2012
Involvement of STAT3, NF-κB and associated downstream molecules before and after the onset of urethane induced lung tumors in mouse
M Pandey, KP Gupta
Environmental Toxicology and Pharmacology 2012
ER stress-induced inflammation: does it aid or impede disease progression?
AD Garg, A Kaczmarek, O Krysko, P Vandenabeele, DV Krysko, P Agostinis
Trends in Molecular Medicine 2012
The role of pseudokinases in cancer
H Zhang, A Photiou, G Arnhild, J Stebbing, G Giamas
Cellular Signalling 2012
Mesenchymal stem cells enhance lung cancer initiation through activation of IL-6/JAK2/STAT3 pathway
HS Hsu, JH Lin, TW Hsu, K Su, CW Wang, KY Yang, SH Chiou, SC Hung
Lung Cancer 2012
Notch-Induced hIL-6 Production Facilitates the Maintenance of Self-Renewal of hCD34+ Cord Blood Cells Through the Activation of Jak-PI3K-STAT3 Pathway
B Choi, E Chun, SY Kim, M Kim, KY Lee, SJ Kim
The American Journal of Pathology 2011
Protein kinase CK2 modulates IL-6 expression in inflammatory breast cancer
D Drygin, CB Ho, M Omori, J Bliesath, C Proffitt, R Rice, A Siddiqui-Jain, S O’Brien, C Padgett, JK Lim, K Anderes, WG Rice, D Ryckman
Biochemical and Biophysical Research Communications 2011
Rapid Symptomatic Improvement in Gefitinib-Treated Patients with EGFR-Mutated Lung Cancer: Possible Role of Downregulation of Inflammatory Molecules?
EN Suspitsin, EV Levchenko, FV Moiseyenko, AO Ivantsov, SA Radzhabova, DE Matsko, VM Moiseyenko, EN Imyanitov
Onkologie 2011
Inflamm-aging of the stem cell niche: Breast cancer as a paradigmatic example : Breakdown of the multi-shell cytokine network fuels cancer in aged people
M Bonafè, G Storci, C Franceschi
BioEssays 2011
CK2 Inhibitors Enhance the Radiosensitivity of Human Non-Small Cell Lung Cancer Cells Through Inhibition of Stat3 Activation
YC Lin, MS Hung, CK Lin, JM Li, KD Lee, YC Li, MF Chen, JK Chen, CT Yang
Cancer Biotherapy & Radiopharmaceuticals 2011
Mathematical model of the role of intercellular signalling in intercellular cooperation during tumorigenesis
S Ghosh, S Elankumaran, IK Puri
Cell Proliferation 2011
STAT3 expression in activating EGFR-driven adenocarcinoma of the lung
S Takata, N Takigawa, Y Segawa, T Kubo, K Ohashi, T Kozuki, N Teramoto, M Yamashita, S Toyooka, M Tanimoto, K Kiura
Lung Cancer 2011
Prolonged mammosphere culture of MCF-7 cells induces an EMT and repression of the estrogen receptor by microRNAs
IK Guttilla, KN Phoenix, X Hong, JS Tirnauer, KP Claffey, BA White
Breast Cancer Research and Treatment 2011
The soluble Interleukin 6 receptor: Generation and role in inflammation and cancer
A Chalaris, C Garbers, B Rabe, S Rose-John, J Scheller
European Journal of Cell Biology 2011
Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells
I Kryczek, S Liu, M Roh, L Vatan, W Szeliga, S Wei, M Banerjee, Y Mao, J Kotarski, MS Wicha, R Liu, W Zou
International Journal of Cancer 2011
Blocking the IL-6–STAT3 signaling pathway: potential liver cancer therapy
Y Liu, J Lin
Future Oncology 2011
Correlation of Activated STAT3 Expression with Clinicopathologic Features in Lung Adenocarcinoma and Squamous Cell Carcinoma
R Jiang, Z Jin, Z Liu, L Sun, L Wang, K Li
Molecular diagnosis & therapy 2011
Ultraviolet light induces Stat3 activation in human keratinocytes and fibroblasts through reactive oxygen species and DNA damage
T Bito, N Sumita, T Masaki, T Shirakawa, M Ueda, R Yoshiki, Y Tokura, C Nishigori
Experimental Dermatology 2010
SR16388: a steroidal antiangiogenic agent with potent inhibitory effect on tumor growth in vivo
WR Chao, K Amin, Y Shi, P Hobbs, M Tanabe, M Tanga, L Jong, N Collins, R Peters, K Laderoute, D Dinh, D Yean, C Hou, B Sato, C Alt, L Sambucetti
Angiogenesis 2010
Inflaming resistance to Tarceva
C Cain
Science-Business eXchange 2010